News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Changes in PledPharma’s Board of Directors and committees

July 30, 2020

PledPharma AB (STO: PLED) today announced that Marie Ekström Trägårdh has chosen to step down from the company's Board of Directors due to private reasons.

The duties and responsibilities of the Remuneration Committee and the Audit Committee will from now be taken on by the Board of Directors. Members of both these committees consisted previously of Håkan Åström, Chairman of the Board, and Marie Ekström Trägårdh.



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10